Testing the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy Treatment During Radiation Therapy for Superior Sulcus Non-small Cell Lung Cancer
Condition(s):Lung Non-Small Cell Carcinoma; Stage IIB Lung Cancer AJCC v8; Stage IIIA Lung Cancer AJCC v8; Superior Sulcus Lung CarcinomaLast Updated:September 26, 2023Withdrawn